Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 19/20 | 1.00 |
| ▸ | TSHR | P16473 | 2/20 | 0.61 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.61 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.57 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.57 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.57 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.57 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.57 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.57 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.57 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.57 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.57 |
| ▸ | HTR2A | P28223 | 1/20 | 0.57 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.57 |
| ▸ | MC4R | P32245 | 1/20 | 0.57 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.57 |
| ▸ | MC3R | P41968 | 1/20 | 0.57 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29854020 | 1.00 | ADRB2 (1.00) | ADRB2TSHRHIF1AADRA1ACYP3A4 | |
| SCHEMBL2488460 | 1.00 | ADRB2 (1.00) | ADRB2TSHRHIF1AADRA1ACYP3A4 | |
| Fumaric Acid SCHEMBL2795621 | 0.90 | ADRB2 (0.81) | ADRB2TSHRHIF1AADRA1ACYP3A4 | |
| Fumaric Acid SCHEMBL2791926 | 0.90 | ADRB2 (0.81) | ADRB2TSHRHIF1AADRA1ACYP3A4 | |
| Fumaric Acid SCHEMBL2797747 | 0.90 | ADRB2 (0.81) | ADRB2TSHRHIF1AADRA1ACYP3A4 | |
| Fumaric Acid SCHEMBL2794710 | 0.90 | ADRB2 (0.81) | ADRB2TSHRHIF1AADRA1ACYP3A4 | |
| Fumaric Acid SCHEMBL2791932 | 0.90 | ADRB2 (0.81) | ADRB2TSHRHIF1AADRA1ACYP3A4 | |
| Fumaric Acid SCHEMBL2795627 | 0.90 | ADRB2 (0.81) | ADRB2TSHRHIF1AADRA1ACYP3A4 | |
| Fumaric Acid SCHEMBL2791924 | 0.90 | ADRB2 (0.81) | ADRB2TSHRHIF1AADRA1ACYP3A4 | |
| Fumaric Acid SCHEMBL2791936 | 0.90 | ADRB2 (0.81) | ADRB2TSHRHIF1AADRA1ACYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025224043-A1 | CHIRAL AMINOPHOSPHINE LIGANDS, IRIDIUM CATALYSTS COMPRISING THESE LIGANDS AND USE OF THESE CATALYSTS IN ASYMMETRIC HYDROGENATIONS | F. HOFFMANN-LA ROCHE AG (CH) | 2025-10-30 | — | — | WO | disclosed |
| EP-4613730-A1 | LIPIDIC ALKYNYLCARBINOLS WITH ANTI-BACTERIAL AND ANTI-TUBERCULOSIS ACTIVITY | Centre National de la Recherche Scientifique (FR) | 2025-09-10 | — | — | EP | disclosed |
| EP-4277885-B1 | PROCESS FOR THE PREPARATION OF A CHIRAL TRIOL | HOFFMANN LA ROCHE (CH) | 2025-02-26 | — | — | EP | disclosed |
| EP-3634379-B1 | QUICKLY DISINTEGRATING FOAM WAFER WITH HIGH MASS PER UNIT AREA | LTS LOHMANN THERAPIE SYSTEME AG (DE) | 2024-08-28 | — | — | EP | disclosed |
| US-20240018076-A1 | PROCESS FOR THE PREPARATION OF A CHIRAL TRIOL | HOFFMANN-LA ROCHE INC. (US) | 2024-01-18 | — | — | US | disclosed |
| WO-2023022231-A1 | REVERSIBLE COVALENT BINDING INHIBITOR FOR TREATING OR PREVENTING VIRAL INFECTION | 国立大学法人九州大学 | 2023-02-23 | — | — | WO | disclosed |
| US-11542479-B2 | Alcohol dehydrogenase mutant and use thereof | JIANGNAN UNIVERSITY (CN) | 2023-01-03 | — | — | US | disclosed |
| CN-115093409-A | Method for synthesizing moxifloxacin side chain by continuous hydrodebenzylation in microreactor | 河南新天地药业股份有限公司 | 2022-09-23 | — | — | CN | disclosed |
| EP-2544676-A1 | THE USE OF FENOTEROL AND FENOTEROL ANALOGUES IN THE TREATMENT OF GLIOBLASTOMAS AND ASTROCYTOMAS | The United States of America, as represented by The Secretary, Department of Health and Human Services (US) | 2013-01-16 | — | — | EP | disclosed |
| WO-2011112867-A1 | THE USE OF FENOTEROL AND FENOTEROL ANALOGUES IN THE TREATMENT OF GLIOBLASTOMAS AND ASTROCYTOMAS | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPT. OF HEALTH AND HUMAN SERVICES (US) | 2011-09-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240018076-A1 | PROCESS FOR THE PREPARATION OF A CHIRAL TRIOL | HMGCR, CETP, MTTP | ADRB2 555/4885TSHR 422/4885HIF1A 4329/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.